Suchergebnisse - "Cui, Xuewei"

PubPharm (52)

1

Dehydrocurvularin-loaded mPEG-PLGA nanoparticles for targeted breast cancer drug delivery : preparation, characterization, in vitro, and in vivo evaluation

enthalten in: Journal of drug targeting | 2024

von Cui, X. | He, Z. | Liang, J. | +5

2

Innovative molecular subtypes of multiple signaling pathways in colon cancer and validation of FMOD as a prognostic-related marker

enthalten in: Journal of cancer research and clinical oncology | 2023

von Dai, Z. | Peng, X. | Cui, X. | +5

3

Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes : A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2023

von Viljoen, A. | Pantalone, K. | Galindo, R. | +5

4

Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies (SURPASS programme)

enthalten in: Diabetes, obesity & metabolism | 2023

von Kiyosue, A. | Dunn, J. | Cui, X. | +4

5

Preparation method of breast cancer targeted nano drug delivery system

enthalten in: Europäisches Patentamt | 2023

von DENG ZHANGSHUANG | CUI XUEWEI | QIN YE | +2

6

Preparation method of breast cancer targeted nano drug delivery system

enthalten in: Europäisches Patentamt | 2023

von DENG ZHANGSHUANG | CUI XUEWEI | QIN YE | +2

7

Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes: A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3

enthalten in: Diabetes therapy | 2023

von Viljoen, A. | Pantalone, K. | Galindo, R. | +5

8

Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes: A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3

enthalten in: Diabetes therapy | 2023

von Viljoen, A. | Pantalone, K. | Galindo, R. | +5

9

Time to Reach Glycaemic and Body Weight Loss Thresholds with Tirzepatide in Patients with Type 2 Diabetes: A Pre-planned Exploratory Analysis of SURPASS-2 and SURPASS-3

enthalten in: Diabetes therapy | 2023

von Viljoen, A. | Pantalone, K. | Galindo, R. | +5

10

Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes : insights from SURPASS clinical program

enthalten in: Cardiovascular diabetology | 2023

von Lingvay, I. | Mosenzon, O. | Brown, K. | +4

1
2
3
4
5
6
Nächster »
[6]